Plain-English translation of NCT06800664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach called HOPE (Home-based self-sampling for cervical cancer Prevention Education) that combines at-home cervical cancer screening with supportive counseling. The program is designed specifically for women living with HIV in Ghana, where cervical cancer rates are much higher for this group. Researchers want to see if this home-based approach, combined with training for healthcare providers and facilities, can help more women get screened regularly.
Women living with HIV in Ghana are six times more likely to develop cervical cancer, but less than 3% of eligible women are getting screened. This trial exists to find a practical, acceptable way to increase screening rates by bringing the test home and pairing it with culturally respectful counseling.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be placed in one of two groups. One group will receive training and support from their healthcare facility to use the home-based screening approach, while the control group will receive standard care. As a participant, you would receive a self-sampling kit to use at home to collect a cervical sample, along with counseling and education using the three-part communication model designed to help you feel more comfortable with screening. The study involves work with healthcare providers and facilities to integrate this approach into regular care.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
Ghana